Table 3.
Regression modelling results, including slopes, significance levels and E-values for cannabis herb THC concentration–cancer relationship slopes by mixed-effects regression.
| Cancer | β-Estimate | Std. Error | p-Value | P. Adj. Holm | E-Value Estimate | E-Value Lower Bound |
|---|---|---|---|---|---|---|
| All Cancers nNMSC | 2.6457 | 0.0778 | 4.69 × 10−180 | 1.41 × 10−178 | 4.88 × 1013 | 8.28 × 1012 |
| All Cancers | 2.8076 | 0.1071 | 6.70 × 10−102 | 1.94 × 10−100 | 3.15 × 1010 | 5.46 × 109 |
| Prostate | 5.2624 | 0.2489 | 1.55 × 10−86 | 4.35 × 10−85 | 4.59 × 107 | 9.56 × 106 |
| Breast | 2.4686 | 0.1369 | 1.36 × 10−65 | 3.67 × 10−64 | 3.51 × 106 | 7.37 × 105 |
| Melanoma | 5.9745 | 0.3598 | 8.89 × 10−57 | 2.31 × 10−55 | 5.59 × 105 | 1.28 × 105 |
| Kidney | 3.5398 | 0.2357 | 1.64 × 10−47 | 4.11 × 10−46 | 3.32 × 105 | 6.95 × 104 |
| Colorectum | 2.5415 | 0.1742 | 4.61 × 10−45 | 1.11 × 10−43 | 2.03 × 105 | 4.33 × 104 |
| Pancreas | 3.6625 | 0.2554 | 1.04 × 10−43 | 2.40 × 10−42 | 1.67 × 105 | 3.55 × 104 |
| Testis | 4.5855 | 0.3263 | 2.84 × 10−41 | 6.25 × 10−40 | 5.74 × 107 | 5.26 × 106 |
| Thyroid | 4.9267 | 0.3666 | 3.26 × 10−38 | 6.85 × 10−37 | 8.56 × 107 | 6.63 × 106 |
| Non-Hodgkin’s Lymphoma | 3.7844 | 0.2854 | 7.36 × 10−38 | 1.47 × 10−36 | 6.82 × 104 | 1.46 × 104 |
| Lung | 2.0357 | 0.1687 | 5.35 × 10−32 | 1.02 × 10−30 | 3.40 × 104 | 7.01 × 103 |
| Anus | 3.6672 | 0.3097 | 1.61 × 10−30 | 2.89 × 10−29 | 2.77 × 106 | 2.68 × 105 |
| Oesophagus | 3.5244 | 0.3847 | 1.71 × 10−19 | 2.90 × 10−18 | 2.58 × 103 | 557.87 |
| Leukaemia—Myeloid | 4.2458 | 0.6638 | 8.92 × 10−10 | 1.43 × 10−8 | 2.22 × 105 | 6.35 × 103 |
| Oropharynx_Broad | 2.5577 | 0.4523 | 2.82 × 10−8 | 4.23 × 10−7 | 5.05 × 102 | 74.07 |
| Leukaemia—Lymphoid | 1.6165 | 0.4299 | 2.16 × 10−4 | 0.0026 | 1784.06 | 51.56 |
| Brain | 1.1480 | 0.3174 | 3.09 × 10−4 | 0.0034 | 19.93 | 5.26 |
| Myeloma | 0.8656 | 0.2619 | 9.80 × 10−4 | 0.0098 | 127.86 | 10.41 |
| Corpus Uteri | 1.2936 | 0.4601 | 0.0050 | 0.0400 | 16.44 | 3.24 |
| Liver | 0.7809 | 0.3581 | 0.0294 | 0.2059 | 37.76 | 2.05 |
| Hodgkin’s | 0.4718 | 0.3032 | 0.1200 | 0.5999 | 12.08 | 1.00 |
| Cervix | 0.1742 | 0.3411 | 0.6097 | 1.0000 | 2.38 | 1.00 |
| Bladder | 0.0250 | 0.2849 | 0.9302 | 1.0000 | 1.35 | 1.00 |
| Kaposi | 0.0346 | 0.4840 | 0.9432 | 1.0000 | 2.09 | 1.00 |
| Ovary | −0.0127 | 0.3205 | 0.9684 | 1.0000 | 1.21 | - |
| Oropharynx | −2.7034 | 1.4854 | 0.0699 | 0.4192 | 54.33 | - |
| Gallbladder and Biliary | −1.1202 | 0.3420 | 0.0011 | 0.0098 | 487.89 | - |
| Larynx | −1.3647 | 0.3578 | 1.42 × 10−4 | 0.0018 | 27.57 | - |
| Stomach | −0.8809 | 0.2164 | 4.92 × 10−5 | 6.89 × 10−4 | 53.25 | - |
Table key: β-Estimate—estimate of the regression coefficient; Std. Error—standard error of the regression coefficient; p-value—significance level; P. Adj. Holm—p-value adjusted for multiple testing by the method of Holm; E-value—expected value required of some unknown confounder covariate with both the exposure and the outcome to explain the observed effect; lower bound of the E-value—the 95% lower bound of the confidence interval of the E-value.